RxDoctor Payments Data

Laurel Lawrence, APRN

Adult Health · Winter Haven, FLNPI 1730614405

Payments from drug & device makers

$1,548in general payments, 2019–2025

Across 71 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$298
  • Calliditas Therapeutics US Inc.$250
  • Mallinckrodt Hospital Products Inc.$125
  • Boehringer Ingelheim$121
  • Fresenius USA Marketing, Inc.$116
  • Aurinia Pharma U.S., Inc.$115
  • plus $524 from 11 others

What the payments were for

  • Food & beverage$1,53599%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,548 in reported general payments places this provider in the 70th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$12,418
Medicare patients
76
Services billed
643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide11$26,209
Sevelamer Carbonate29$13,797
FarxigaDapagliflozin Propanediol16$10,459
JardianceEmpagliflozin13$9,812
Nifedipine ErNifedipine39$1,412
Calcitriol47$610
Terazosin Hcl47$560
Hydralazine Hcl15$543
Labetalol Hcl13$531
Carvedilol63$495
Lisinopril70$412
Allopurinol29$365
Furosemide79$358
Potassium Chloride14$335
Spironolactone22$316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$116$26,20911 claims
AstraZenecaFarxiga$58$10,45916 claims
Boehringer IngelheimJardiance$121$9,81213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,237 adult health providers in Florida.

Other adult health in Winter Haven

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →